The multifaceted nature of nlrp12

Journal of Leukocyte Biology

Volumn 96, Issue 6, 2014, Pages 991-1000

  Tuncer, Sinem ^a   Fiorillo, Maria Teresa ^a   Sorrentino, Rosa ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cancer; Infection; Inflammasome; NF B; Nod like receptors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDE BINDING DOMAIN AND LEUCINE RICH REPEAT CONTAINING 12; NUCLEOTIDE BINDING DOMAIN AND LEUCINE RICH REPEAT CONTAINING 5; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROTEIN; UNCLASSIFIED DRUG; MHC CLASS II TRANSACTIVATOR PROTEIN; NLRC5 PROTEIN, HUMAN; NLRP12 PROTEIN, HUMAN; NLRP12 PROTEIN, MOUSE; NUCLEAR PROTEIN; PATTERN RECOGNITION RECEPTOR; RNO PROTEIN, HUMAN; SIGNAL PEPTIDE; TRANSACTIVATOR PROTEIN; TUMOR PROTEIN;

ANTIGEN PRESENTATION; ARTICLE; AUTOINFLAMMATORY DISEASE; CARCINOGENESIS; CELL DEATH; CELL MIGRATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENTERITIS; HOST RESISTANCE; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INFLAMMATION; NEOPLASM; OLIGOMERIZATION; PROCESSING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; BACTERIAL INFECTION; BONE MARROW CELL; CELL MOTION; CLASSIFICATION; COLITIS; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; MOUSE; MULTIGENE FAMILY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ANIMALS; BACTERIAL INFECTIONS; CELL MOVEMENT; COLITIS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAJOR HISTOCOMPATIBILITY COMPLEX; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MULTIGENE FAMILY; MYELOID CELLS; NEOPLASM PROTEINS; NEOPLASMS; NF-KAPPA B; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RECEPTORS, PATTERN RECOGNITION; TRANS-ACTIVATORS;

EID: 84914167092     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3RU0514-265RR     Document Type: Article

References (111)

1. Barton, G. M. (2008) A calculated response: control of inflammation by the innate immune system. J. Clin. Invest. 118, 413-420.
2. Newton, K., Dixit, V. M. (2012) Signaling in innate immunity and inflammation. Cold. Spring Harb. Perspect. Biol. 4, a006049.
3. Takeuchi, O., Akira, S. (2010) Pattern recognition receptors and inflammation. Cell 140, 805-820.
4. Mogersen, T. H. (2009) Pathogen recognition and inflammatory signalling in innate immune defense. Clin. Microbiol. Rev. 22, 240-273.
5. Lee, M. S., Kim, Y-J. (2007) Signaling pathways downstream of patternrecognition receptors and their cross talk. Annu. Rev. Biochem. 76, 447-480.
6. Shaw, S. G., Tsui, J. (2013) Innate immunity: an integrated overview. Heart Metab. 60, 34-37.
7. Zhong, Y., Kinio, A., Saleh, M. (2013) Functions of NOD-like receptors in human diseases. Front. Immunol. 4, 333.
8. Ting, J. P-Y., Davis, B. K. (2005) Caterpiller: a novel gene family important in immunity, cell death, and diseases. Annu. Rev. Immunol. 23, 387-414.
9. Rosenstiel, P., Schreiber, S. (2009) NOD-like receptors—pivotal guardians of the immunological integrity of barrier organs. In Target Pattern Recognition in Innate Immunity (Kishore, U., ed.), Landes Bioscience and Springer Science:Business Media, Austin, TX, USA, 35-47.
10. Shaw, M. H., Reimer, T., Kim, Y. G., Nuñez, G. (2008) NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr. Opin. Immunol. 20, 377-382.
11. Proell, M., Riedl, S. J., Fritz, J. H., Rojas, A. M., Schwarzenbacher, R. (2008) The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS One 3, e2119.
12. Schroder, K., Tschopp, J. (2010) The inflammasomes. Cell 140, 821-832.
13. Kawai, T., Akira, S. (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21, 317-337.
14. Halff, E. F. (2013) Structural and functional studies on Nod like receptors: insights into NAIP/NLRC4 inflammasome formation. Doctoral dissertation, Crystal and Structural Chemistry, Bijvoet Center for Biomolecular Research, Department of Chemistry, Faculty of Science, Utrecht University, The Netherlands.
15. Lupfer, C., Kanneganti, T. D. (2013) Unsolved mysteries in NLR biology. Front. Immunol. 4, 285.
16. Allen, I. C. (2014) Non inflammosome forming NLRs in inflammation and tumorigenesis. Front. Immunol. 5, 169.
17. Choi, N. M., Majumder, P., Boss, J. M. (2011) Regulation of major histocompatibility complex class II genes. Curr. Opin. Immunol. 23, 81-87.
18. Devaiah, B. N., Singer, D. S. (2013) CIITA and its dual roles in MHC gene transcription. Front. Immunol. 4, 476.
19. Zhu, X. S., Linhoff, M. W., Li, G., Chin, K. C., Maity, S. N., Ting, J. P. (2000) Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Mol. Cell. Biol. 20, 6051-6061.
20. Steimle, V., Otten, L. A., Zufferey, M., Mach, B. (2007) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). J. Immunol. 178, 6677-6688.
21. Neerincx, A., Rodriguez, G. M., Steimle, V., Kufer, T. A. (2012) NLRC5 controls basal MHC class I gene expression in an MHC enhanceosomedependent manner. J. Immunol. 188, 4940-4950.
22. Meissner, T. B., Li, A., Kobayashi, K. S. (2012) NLRC5: a newly discovered MHC class I transactivator (CITA). Microbes Infect. 14, 477-484.
23. Verhagen, A. M., Coulson, E. J., Vaux, D. L. (2001) Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol. 2, REVIEWS3009.
24. Dubrez-Daloz, L., Dupoux, A., Cartier, J. (2008) IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle 7, 1036-1046.
25. Chamaillard, M., Girardin, S. E., Viala, J., Philpott, D. J. (2003) Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell. Microbiol. 5, 581-592.
26. Faustin, B., Lartigue, L., Bruey, J. M., Luciano, F., Sergienko, E., Bailly-Maitre, B., Volkmann, N., Hanein, D., Rouiller, I., Reed, J. C. (2007) Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 25, 713-724.
27. Masters, S. L., Gerlic, M., Metcalf, D., Preston, S., Pellegrini, M., O’Donnell, J. A., McArthur, K., Baldwin, T. M., Chevrier, S., Nowell, C. J., Cengia, L. H., Henley, K. J., Collinge, J. E., Kastner, D. L., Feigenbaum, L., Hilton, D. J., Alexander, W. S., Kile, B. T., Croker, B. A. (2012) NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. Immunity 37, 1009-1023.
28. Bruey, J. M., Bruey-Sedano, N., Newman, R., Chandler, S., Stehlik, C., Reed, J. C. (2004) PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kappaB and caspase-1 activation in macrophages. J. Biol. Chem. 279, 51897-51907.
29. Fontalba, A., Gutierrez, O., Fernandez-Luna, J. L. (2007) NLRP2, an inhibitor of the NFkappaB pathway, is transcriptionally activated by NFkappaB and exhibits a nonfunctional allelic variant. J. Immunol. 179, 8519-8524.
30. Meyer, E., Lim, D., Pasha, S., Tee, L. J., Rahman, F., Yates, J. R., Woods C. G., Reik, W., Maher, E.R. (2009) Germline mutation in NLRP2 (NALP2) in a familial imprinting disorder (Beckwith-Wiedemann Syndrome). PLoS Genet. 5, e1000423.
31. Hirota, S. A., Ng, J., Lueng, A., Khajah, M., Parhar, K., Li, Y., Lam, V., Potentier, M. S., Ng, K., Bawa, M., McCafferty, D. M., Rioux, K. P., Ghosh, S., Xavier, R. J., Colgan, S. P., Tschopp, J., Muruve, D., Mac-Donald, J. A., Beck, P. L. (2011) The NLRP3 inflammasome plays key role in the regulation of intestinal homeostasis. Inflamm. Bowel Dis. 17, 1359-1372.
32. Kumar, H., Kumagai, Y., Tsuchida, T., Koenig, P. A., Satoh, T., Guo, Z., Jang, M. H., Saitoh, T., Akira, S., Kawai, T. (2009) Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan. J. Immunol. 183, 8061-8067.
33. Fiorentino, L., Stehlik, C., Oliveira, V., Ariza, M. E., Godzik, A., Reed, J. C. (2002) A novel PAAD-containing protein that modulates NFkappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. J. Biol. Chem. 277, 35333-35340.
34. Cui, J., Li, Y., Zhu, L., Liu, D., Songyang, Z., Wang, H. Y., Wang, H. Y. (2012) NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat. Immunol. 13, 387-395.
35. Jounai, N., Kobiyama, K., Shiina, M., Ogata, K., Ishii, K. J., Takeshita, F. (2011) NLRP4 negatively regulates autophagic processes through an association with beclin1. J. Immunol. 186, 1646-1655.
36. Liu, F., Lo, C. F., Ning, X., Kajkowski, E. M., Jin, M., Chiriac, C., Gonzales, C., Naureckiene, S., Lock, Y. W., Pong, K., Zaleska, M. M., Jacobsen, J. S., Silverman, S., Ozenberger, B. A. (2004) Expression of NALP1 in cerebellar granule neurons stimulates apoptosis. Cell. Signal. 16, 1013-1021.
37. Tong, Z. B., Gold, L., Pfeifer, K. E., Dorward, H., Lee, E., Bondy, C. A., Dean, J., Nelson, L. M. (2000) Mater, a maternal effect gene required for early embryonic development in mice. Nat. Genet. 26, 267-268.
38. Wu, X. (2009) Maternal depletion of NLRP5 blocks early embryogenesis in rhesus macaque monkeys (Macaca mulatta). Hum. Reprod. 24, 415-424.
39. Fernandes, R., Tsuda, C., Perumalsamy, A. L., Naranian, T., Chong, J., Acton, B. M., Tong, Z. B., Nelson, L. M., Jurisicova, A. (2012) NLRP5 mediates mitochondrial function in mouse oocytes and embryos. Biol. Reprod. 86, 1-10.
40. Anand, P. K., Malireddi, R. K., Lukens, J. R., Vogel, P., Bertin, J., Lamkanfi, M., Kanneganti, T. D. (2012) NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 488, 389-393.
41. Chen, G., Liu, M., Wang, F., Bertin, J., Núñez, G. (2011) A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J. Immunol. 186, 7187-7194.
42. Elinav, E., Strowig, T., Kau, A., Henao-Mejia, J., Thaiss, C., Booth, C., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., Flavell, R. A. (2011) NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757.
43. Khare, S., Dorfleutner, A., Bryan, N. B., Yun, C., Radian, A. D., De Almeida, L., Rojanasakul, Y., Stehlik, C. (2012) An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity 36, 464-476.
44. Messaed, C., Chebaro, W., Di Roberto, R. B., Rittore, C., Cheung, A., Arseneau, J., Schneider, A., Chen, M. F., Bernishke, K., Surti, U., Hoffner, L., Sauthier, P., Buckett, W., Qian, J., Lau, N. M., Bagga, R., Engert, J. C., Coullin, P., Touitou, I., Slim, R., H M Collaborative Group (2011) NLRP7 in the spectrum of reproductive wastage: rare nonsynonymous variants confer genetic susceptibility to recurrent reproductive wastage. J. Med. Genet. 48, 540-548.
45. Ulker, V., Gurkan, H., Tozkir, H., Karaman, V., Ozgur, H., Numanoglu, C., Gedikbasi, A., Akbayir, O., Uyguner, Z. O. (2013) Novel NLRP7 mutations in familial recurrent hydatidiform mole: are NLRP7 mutations a risk for recurrent reproductive wastage? Eur. J. Obstet. Gynecol. Reprod. Biol. 170, 188-192.
46. Radian, A. D., de Almeida, L., Dorfleutner, A., Stehlik, C. (2013) NLRP7 and related inflammasome activating pattern recognition receptors and their function in host defense and disease. Microbes Infect. 15, 630-639.
47. Eisenbarth, S. C., Williams, A., Colegio, O. R., Meng, H., Strowig, T., Rongvaux, A., Henao-Mejia, J., Thaiss, C. A., Joly, S., Gonzalez, D. G., Xu, L., Zenewicz, L. A., Haberman, A. M., Elinav, E., Kleinstein, S. H., Sutterwala, F. S., Flavell, R. A. (2012) NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. Nature 484, 510-513.
48. Wang, Y., Hasegawa, M., Imamura, R., Kinoshita, T., Kondo, C., Konaka, K., Suda, T. (2004) PYNOD, a novel Apaf-1/CED4-like protein is an inhibitor of ASC and caspase-1. Int. Immunol. 16, 777-786.
49. Imamura, R., Wang, Y., Kinoshita, T., Suzuki, M., Noda, T., Sagara, J., Taniguchi, S., Okamoto, H., Suda, T. (2010) Anti-inflammatory activity of PYNOD and its mechanism in humans and mice. J. Immunol. 184, 5874-5884.
50. Westerveld, G. H., Korver, C. M., van Pelt, A. M., Leschot, N. J., van der Veen, F., Repping, S., Lombardi, M. P. (2006) Mutations in the testis-specific NALP14 gene in men suffering from spermatogenic failure. Hum. Reprod. 21, 3178-3184.
51. Schneider, M., Zimmermann, A. G., Roberts, R. A., Zhang, L., Swanson, K. V., Wen, H., Davis, B. K., Allen, I. C., Holl, E. K., Ye, Z., Rahman, A. H., Conti, B. J., Eitas, T. K., Koller, B. H., Ting, J. P. (2012) The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-kappaB. Nat. Immunol. 13, 823-831.
52. Gong, Y. N., Shao, F. (2012) Sensing bacterial infections by NAIP receptors in NLRC4 inflammasome activation. Protein Cell 3, 98-105.
53. Meissner, T. B., Li, A., Biswas, A., Lee, K. H., Liu, Y. J., Bayir, E., Iliopoulos, D., van den Elsen, P. J., Kobayashi, K. S. (2010) NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc. Natl. Acad. Sci. USA 107, 13794-13799.
54. Benko, S., Magalhaes, J. G., Philpott, D. J., Girardin, S. E. (2010) NLRC5 limits the activation of inflammatory pathways. J. Immunol. 185, 1681-1691.
55. Cui, J., Zhu, L., Xia, X., Wang, H. Y., Legras, X., Hong, J., Ji, J., Shen, P., Zheng, S., Chen, Z. J., Wang, R. F. (2010) NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 141, 483-496.
56. Neerincx, A., Lautz, K., Menning, M., Kremmer, E., Zigrino, P., Hosel, M., Büning, H., Schwarzenbacher, R., Kufer, T. A. (2010) A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses. J. Biol. Chem. 285, 26223-26232.
57. Davis, B. K., Roberts, R. A., Huang, M. T., Willingham, S. B., Conti, B. J., Brickey, W. J., Barker, B. R., Kwan, M., Taxman, D. J., Accavitti-Loper, M. A., Duncan, J. A., Ting, J. P. (2011) Cutting edge: NLRC5-dependent activation of the inflammasome. J. Immunol. 186, 1333-1337.
58. Arnoult, D., Soares, F., Tattoli, I., Girardin, S. E. (2011) Mitochondria in innate immunity. EMBO Rep. 12, 901-910.
59. Moore, C. B., Bergstralh, D. T., Duncan, J. A., Lei, Y., Morrison, T. E., Zimmermann, A. G., Accavitti-Loper, M. A., Madden, V. J., Sun, L., Ye, Z., Lich, J. D., Heise, M. T., Chen, Z., Ting, J. P. (2008) NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451, 573-577.
60. Allen, I. C., Moore, C. B., Schneider, M., Lei, Y., Davis, B. K., Scull, M. A., Gris, D., Roney, K. E., Zimmermann, A. G., Bowzard, J. B., Ranjan, P., Monroe, K. M., Pickles, R. J., Sambhara, S., Ting, J. P. (2011) NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-_B signaling pathways. Immunity 34, 854-865.
61. Tattoli, I., Carneiro, L. A., Jehanno, M., Magalhaes, J. G., Shu, Y., Philpott, D. J., Arnoult, D., Girardin, S. E. (2008) NLRX1 is a mitochondrial NOD-like receptor that amplifies NFkappaB and JNK pathways by inducing reactive oxygen species production. EMBO Rep. 9, 293-300.
62. Lei, Y., Wen, H., Yu, Y., Taxman, D. J., Zhang, L., Widman, D. G., Swanson, K. V., Wen, K. W., Damania, B., Moore, C. B., Giguère, P. M., Siderovski, D. P., Hiscott, J., Razani, B., Semenkovich, C. F., Chen, X., Ting, J. P. (2012) The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity 36, 933-946.
63. Pauleau, A. L., Murray, P. J. (2003) Role of Nod2 in the response of macrophages to Toll-like receptor agonists. Mol. Cell. Biol. 23, 7531-7539.
64. Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nuñez, G., Flavell, R. A. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734.
65. Park, J. H., Kim, Y. G., McDonald, C., Kanneganti, T. D., Hasegawa, M., Body-Malapel, M., Inohara, N., Núñez, G. (2007) RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178, 2380-2386.
66. Hsu, L. C., Ali, S. R., McGillivray, S., Tseng, P. H., Mariathasan, S., Humke, E. W., Eckmann, L., Powell, J. J., Nizet, V., Dixit, V. M., Karin, M. (2008) A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl. Acad. Sci. USA 105, 7803-7808.
67. Wagner, R. N., Proell, M., Kufer, T. A., Schwarzenbacher, R. (2009) Evaluation of Nod like receptor (NLR) effector domain interactions. PloS One 4, e4931.
68. Travassos, L. H., Carneiro, L. A., Ramjeet, M., Hussey, S., Kim, Y. G., Magalhães, J. G., Yuan, L., Soares, F., Chea, E., Le Bourhis, L., Boneca, I. G., Allaoui, A., Jones, N. L., Nuñez, G., Girardin, S. E., Philpott, D. J. (2010) Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 11, 55-62.
69. Mercier, B. C., Ventre, E., Fogeron, M. L., Debaud, A. L., Tomkowiak, M., Marvel, J., Bonnefoy, N. (2012) NOD1 cooperates with TLR2 to enhance T cell receptor-mediated activation in CD8 T cells. PLoS One 7, e42170.
70. Petterson, T., Jendholm, J., Mansson, A., Bjartell, A., Riesbeck, K., Cardell, L. O. (2011) Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptors. J. Leukoc. Biol. 89, 177-187.
71. Sabbah, A., Chang, T. H., Harnack, R., Frohlich, V., Tominaga, K., Dube, P. H., Xiang, Y., Bose, S. (2009) Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10, 1073-1080.
72. Van Beelen, A. J., Zelinkova, Z., Taanman-Kueter, E. W., Muller, F. J., Hommes, D. W., Zaat, S. A., Kapsenberg, M. L., de Jong, E. C. (2007) Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27, 660-669.
73. Wu, X., Lahiri, A., Haines G. K., III, Flavell, R. A., Abraham, C. (2014) NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury. J. Immunol. 19, 3409-3418.
74. Rahman, M. K., Midtling, E. H., Svingen, P. A., Xiong, Y., Bell, M. P., Tung, J., Smyrk, T., Egan, L. J., Faubion W. A., Jr., (2010) The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival. J. Immunol. 184, 7247-7256.
75. Shaw, M. H., Reimer, T., Sanchez-Valdepenas, C., Warner, N., Kim, Y. G., Fresno, M., Nuñez, G. (2009) T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii. Nat. Immunol. 10, 1267-1274.
76. Kavathas, P. B., Boeras, C. M., Mulla, M. J., Abrahams, V. M. (2013) Nod1, but not the ASC inflammasome, contributes to induction of IL-1_secretion in human trophoblasts after sensing of Chlamydia trachomatis. Mucosal Immunol. 6, 235-243.
77. Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., Valvano, M. A., Foster, S. J., Mak, T. W., Nuñez, G., Inohara, N. (2003) An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4, 702-707.
78. Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J., Sansonetti, P. J. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872.
79. Bertrand, M. J., Doiron, K., Labbé, K., Korneluk, R. G., Barker, P. A., Saleh, M. (2009) Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 30, 789-801.
80. Xie, P. (2013) TRAF molecules in cell signaling and in human diseases. J. Mol. Signal. 8, 7.
81. Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J. P., Belaiche, J., Almer, S., Tysk, C., O’Morain, C. A., Gassull, M., Binder, V., Finkel, Y., Cortot, A., Modigliani, R., Laurent-Puig, P., Gower-Rousseau, C., Macry, J., Colombel, J. F., Sahbatou, M., Thomas, G. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411, 599-603.
82. Kanazawa, N., Okafuji, I., Kambe, N., Nishikomori, R., Nakata-Hizume, M., Nagai, S., Fuji, A., Yuasa, T., Manki, A., Sakurai, Y., Nakajima, M., Kobayashi, H., Fujiwara, I., Tsutsumi, H., Utani, A., Nishigori, C., Heike, T., Nakahata, T., Miyachi, Y. (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105, 1195-1197.
83. Hysi, P., Kabesch, M., Moffatt, M. F., Schedel, M., Carr, D., Zhang, Y., Boardman, B., von Mutius, E., Weiland, S. K., Leupold, W., Fritzsch, C., Klopp, N., Musk, A. W., James, A., Nunez, G., Inohara, N., Cookson, W. O. (2005) NOD1 variation, immunoglobulin E and asthma. Hum. Mol. Genet. 14, 935-941.
84. Weidinger, S., Klopp, N., Rummler, L., Wagenpfeil, S., Novak, N., Baurecht, H. J., Groer, W., Darsow, U., Heinrich, J., Gauger, A., Schafer, T., Jakob, T., Behrendt, H., Wichmann, H. E., Ring, J., Illig, T. (2005) Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J. Allergy Clin. Immunol. 116, 177-184.
85. Jha, S., Ting, J. P. (2009) Inflammasome-associated nucleotide-binding domain, leucine-rich repeat proteins and inflammatory diseases. J. Immunol. 183, 7623-7629.
86. Holler, E., Landfried, K., Meier, J., Hausmann, M., Rogler, G. (2010) The role of bacteria and pattern recognition receptors in GVHD. Int. J. Inflamm. 2010, 814326.
87. Bauernfeind, F., Hornung, V. (2013) Of inflammasomes and pathogens— sensing of microbes by the inflammasome. EMBO Mol. Med. 5, 814-826.
88. Baroja-Mazo, A., Martín-Sánchez, F., Gomez, A. I., Martínez, C. M., Amores-Iniesta, J., Compan, V., Barberà-Cremades, M., Yagüe, J., Ruiz-Ortiz, E., Antón, J., Buján, S., Couillin, I., Brough, D., Arostegui, J. I., Pelegrín, P. (2014) The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat. Immunol. 15, 738-748.
89. Franklin, B. S., Bossaller, L., De Nardo, D., Ratter, J. M., Stutz, A., Engels, G., Brenker, C., Nordhoff, M., Mirandola, S. R., Al-Amoudi, A., Mangan, M. S., Zimmer, S., Monks, B. G., Fricke, M., Schmidt, R. E., Espevik, T., Jones, B., Jarnicki, A. G., Hansbro, P. M., Busto, P., Marshak-Rothstein, A., Hornemann, S., Aguzzi, A., Kastenmüller, W., Latz, E. (2014) The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation. Nat. Immunol. 15, 727-737.
90. Kinoshita, T., Wang, Y., Hasegawa, M., Imamura, R., Suda, T. (2005) PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin1beta secretion. J. Biol. Chem. 280, 21720-21725.
91. Williams, K. L., Lich, J. D., Duncan, J. A., Reed, W., Rallabhandi, P., Moore, C., Kurtz, S., Coffield, V. M., Accavitti-Loper, M. A., Su, L., Vogel, S. N., Braunstein, M., Ting, J. P. (2005) The caterpiller protein Monarch-1 is an antagonist of Toll like receptor-, tumor necrosis factor_-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. J. Biol. Chem. 280, 39914-39924.
92. Shami, P. J., Kanai, N., Wang, L. Y., Vreeke, T. M., Parker, C. J. (2001) Identification and characterization of a novel gene that is upregulated in leukaemia cells by nitric oxide. Br. J. Haematol. 112, 138-147.
93. Williams, K. L., Taxman, D. J., Linhoff, M. W., Reed, W., Ting, J. P. (2003) Cutting edge: Monarch-1: a pyrin/nucleotide-binding domain/leucine-rich repeat protein that controls classical and nonclassical MHC class I genes. J. Immunol. 170, 5354-5358.
94. Wang, L., Manji, G. A., Grenier, J. M., Al-Garawi, A., Merriam, S., Lora, J. M., Geddes, B. J., Briskin, M., DiStefano, P. S., Bertin, J. (2002) PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J. Biol. Chem. 277, 29874-29880.
95. Ye, Z., Lich, J. D., Moore, C. B., Duncan, J. A., Williams, K. L., Ting, J. P. (2008) ATP binding by Monarch-1/NLRP12 is critical for its inhibitory function. Mol. Cell. Biol. 28, 1841-1850.
96. Wu, M. F., Chen, S. T., Hsieh, S. L. (2013) Distinct regulation of dengue virus-induced inflammasome activation in human macrophage subsets. J. Biomed. Sci. 20, 36.
97. Lord, C. A., Savitsky, D., Sitcheran, R., Calame, K., Wright, J. R., Ting, J. P., Williams, K. L. (2009) Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene, NLRP12/Monarch-1. J. Immunol. 182, 2948-2958.
98. Arthur, J., Lich, J. D., Aziz, R. K., Kotb, M., Ting, J. P. (2007) Heat shock protein 90 associates with monarch-1 and regulates its ability to promote degradation of NF-kappaBinducing kinase. J. Immunol. 179, 6291-6296.
99. Lich, J. D., Williams, K. L., Moore, C. B., Arthur, J. C., Davis, B. K., Taxman, D. J., Ting, J. P. (2007) Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. J. Immunol. 178, 1256-1260.
100. Zaki, M. H., Vogel, P., Malireddi, R. K., Body-Malapel, M., Anand, P. K., Bertin, J., Green, D. R., Lamkanfi, M., Kanneganti, T. D. (2011) The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 20, 649-660.
101. Allen, I. C., Wilson, J. E., Schneider, M., Lich, J. D., Roberts, R. A., Arthur, J. C., Woodford, R. M., Davis, B. K., Uronis, J. M., Herfarth, H. H., Jobin, C., Rogers, A. B., Ting, J. P. (2012) NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-kB signaling. Immunity 36, 742-754.
102. Liao, G., Zhang, M., Harhaj, E. W., Sun, S. C. (2004) Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279, 26243-26250.
103. Vladimer, G. I., Weng, D., Paquette, S. W., Vanaja, S. K., Rathinam, V. A., Aune, M. H., Conlon, J. E., Burbage, J. J., Proulx, M. K., Liu, Q., Reed, G., Mecsas, J. C., Iwakura, Y., Bertin, J., Goguen, J. D., Fitzgerald, K. A., Lien, E. (2012) The NLRP12 inflammasome recognizes Yersinia pestis. Immunity 37, 96-107.
104. Allen, C. I., McElvania-TeKippe, E., Wilson, J. E., Lich, J. D., Arthur, J. C., Sullivan, J. T., Braunstein, M., Ting, J. P. (2013) Characterization of NLRP12 during the in vivo host immune response to Klebsiella pneumoniae and Mycobacterium tuberculosis. PLoS One 8, e60842.
105. Zaki, M. H., Man, S. M., Vogel, P., Lamkanfi, M., Kanneganti, T. D. (2014) Salmonella exploits NLRP12-dependent innate immune signaling to suppress host defenses during infection. Proc. Natl. Acad. Sci. USA 111, 385-390.
106. Ataide, M. A., Andrade, W. A., Zamboni, D. S., Wang, D., Souza Mdo, C., Franklin, B. S., Elian, S., Martins, F. S., Pereira, D., Reed, G., Fitzgerald, K. A., Golenbock, D. T., Gazzinelli, R. T. (2014) Malariainduced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. PLoS Pathog. 10, e1003885.
107. Jeru, I., Duquesnoy, D., Fernandes-Alnemri, T., Cochet, E., Yu, J. W., Lackmy-Port-Lis, M., Grimprel, E., Landman-Parker, J., Hentgen, V., Marlin, S., McElreavey, K., Sarkisian, T., Grateau, G., Alnemri, E.S., Amselem, S. (2008) Mutations in NALP12 cause hereditary periodic fever syndromes. Proc. Natl. Acad. Sci. USA 105, 1614-1619.
108. Borghini, S., Tassi, S., Chiesa, S., Caroli, F., Carta, S., Caorsi, R., Fiore, M., Delfino, L., Lasigliè, D., Ferraris, C., Traggiai, E., Di Duca, M., Santamaria, G., D’Osualdo, A., Tosca, M., Martini, A., Ceccherini, I., Rubartelli, A., Gattorno, M. (2011) Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation. Arthritis Rheum. 63, 830-839.
109. Jéru, I., Le Borgne, G., Cochet, E., Hayrapetyan, H., Duquesnoy, P., Grateau, G., Morali, A., Sarkisian, T., Amselem, S. (2011) Identification and functional consequences of a recurrent NLRP12 missense mutation in periodic fever syndromes. Arthritis Rheum. 63, 1459-1464.
110. Jéru, I., Hentgen, V., Normand, S., Duquesnoy, P., Cochet, E., Delwail, A., Grateau, G., Marlin, S., Amselem, S., Lecron, J. C. (2011) Role of interleukin-1_in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy. Arthritis Rheum. 63, 2142-2148.
111. Arthur, J. C., Lich, J. D., Ye, Z., Allen, I. C., Gris, D., Wilson, J. E., Schneider, M., Roney, K. E., O’Connor, B. P., Moore, C. B., Morrison, A., Sutterwala, F. S., Bertin, J., Koller, B. H., Liu, Z., Ting, J. P. (2010) Cutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity. J. Immunol. 185, 4515-4519.